• In 2021, Lexaria conducted several main studies evaluating DehydraTECH-processed CBD and nicotine
• The company has big plans for 2022, a year it expects to undertake three ground-breaking studies
• Lexaria hopes these three major studies will generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnerships
• The company is eying larger national and international applications for DehydraTECH with the aim of generating revenue through licensing fees and royalties

For Lexaria Bioscience (NASDAQ: LEXX), a drug delivery company whose patented DehydraTECH(TM) technology has proven effective in improving bioavailability, speed of onset, and efficiency of orally-delivered fat-soluble active molecules and pharmaceuticals, 2021 was a year of myriad milestones. In an annual letter to shareholders, company CEO Chris Bunka underlined that January 2021 marked the birth of a modern version of the company (https://ibn.fm/Djp5l). “During 2021, we completed research & development (‘R&D’) and validating work equal to or greater than all the combined amount previously completed since 2018! We have conducted studies across broad areas of interest, but also concentrated in specific areas where we have had supportive data,” writes Bunka. Last year, Lexaria’s most significant area of investigation was DehydraTECH-processed cannabidiol (“CBD”) for the potential treatment of hypertension and heart disease. The company conducted HYPER-H21-1, its first human study of 2021, that showed that human blood pressure (“BP”) decreased within minutes of ingesting a single dose of DehydraTECH-CBD capsules. Its follow-up study, HYPER-H21-2, in which participants received three doses of DehydraTECH-CBD and were monitored over a 24-hour ambulatory period, showed a 23% average decrease in BP, relative to placebo, among patients with mild to moderate hypertension. Over the 24 hours, the reduction in BP averaged 7.0%. The study also evidenced reduced arterial stiffness among the volunteers. Encouraged by the findings and building on the same, Lexaria has big plans for 2022. Starting in April or possibly sooner, the company plans to begin dosing in its largest-ever hypertension study. “If this study is successful, we feel strongly that it will be highly supportive of our IND filing plan, and we will have a clear path toward designing of Phase 1 and even potentially Phase II FDA-registered clinical studies thereunder. Assuming there are no major delays either in study execution or evaluation, we expect full results from this study sometime in Q3, 2022,” Bunka adds. Bunka also expressed the company’s plans to expand its DehydraTECH-CBD program by exploring other development opportunities. Specifically, before this Spring, Lexaria expects to launch a complex animal study to evaluate DehydraTECH-CBD as a potential treatment to inhibit seizure activity in animals. The company has also announced its intention to pursue efficacy modeling through 2022 with its DehydraTECH-CBD in animals for other possible therapeutic indications, namely dementia, rheumatoid diseases, and diabetes. In addition, 2021 saw the company undertake a nicotine animal study wherein it evidenced that DehydraTECH effectively promoted nicotine delivery characteristics in sublingual/buccal (oral tissue). The study offered yet another opportunity for the company to demonstrate DehydraTECH’s versatility to work effectively in different parts of the body, opening doors to drug delivery through multiple other products. Based on these successes, Lexaria plans to launch a similar study in humans, expected to “start soon.” Bunka believes that if the company demonstrates a similar performance of nicotine absorption in humans, it will have achieved another significant milestone as it journeys toward the commercial applicability of its technology. Further, Bunka voices his enthusiasm at 2022, noting: “The goal of our three major studies is to generate sufficient data to support either regulated IND-type applications or to stimulate corporate partnering within their appropriate market sectors. We are optimistic of positive results – noting that science can be unpredictable – and, if so, expect 2022 to be our most exciting year ever!” In addition, Lexaria strengthened its IP portfolio with the receipt of five new patents in 2021, which brought its total to 23 granted globally. As well, it up-listed to the Nasdaq Capital Markets, where it raised $11 million in gross proceeds budgeted to finance its R&D initiatives and operations. Bunka also lays stress on the company’s longer-term goals as regards revenue generation. Whereas Lexaria generated its highest-ever revenues in 2021 of over $720,000, mainly due to its DehydraTECH licensing arrangements with its existing clients, the company is primarily focusing on larger national and international applications for DehydraTECH, chiefly but not limited to the pharmaceutical sector. Accordingly, Lexaria is targeting licensing fees, milestone payments as well as royalties. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Mydecine has summitted a pre-IND briefing package to the FDA in readiness for its phase 2/3 smoking cessation trial scheduled for Q2 2022
• The study will be led by Dr. Matthew Johnson, with the placebo-controlled research being conducted at Johns Hopkins University
• Mydecine also announced its partnership with Combat Stress to use psilocybin in a psychoactive-assisted psychotherapy PTSD treatment program for veterans
• Combat Stress will also be one of several sites for the company’s upcoming clinical trials set to launch later in the year

Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) plans to launch its seamless phase 2/3 smoking cessation clinical trial in the second quarter (“Q2”) of the 2022 financial year, with primary endpoints of three and six months. The study will build previous research conducted by Dr. Matthew Johnson, Ph.D., and his team at Johns Hopkins University. Their ongoing study is showing 59% of participants who received psychedelic-assisted therapy remained abstinent from smoking at 12 months. In comparison, only 28% of patients who received the transdermal nicotine patch remained abstinent (https://ibn.fm/KvEUG). In readiness for the trial, Mydecine has submitted a pre-Investigational New Drug (“IND”) briefing package to the United States Food and Drug Administration (“FDA”). The submission will allow the company to evaluate its lead drug candidate, MYCO-001, in a structured smoking cessation treatment program, aiming to introduce the product in the market as early as 2024. “We are excited to move forward on this important study, and our team has been working diligently to ensure that our pre-IND package is complete,” noted Josh Bartch, the Chief executive Officer (“CEO”) of Mydecine. “As the only company currently investigating a psilocybin compound for smoking cessation, Mydecine is proud to be at the forefront of this research,” he added. Dr. Johnson, a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University (“JHU”), will be the Principal Investigator in this clinical study. The planned placebo-controlled study will be conducted at JHU, and the research will feature a combined phase that will utilize results acquired throughout the trial to adjust the course of the study. According to the Centers for Disease Control and Prevention (“CDC”), in the United States alone, cigarette smoking is responsible for one out of every five deaths, representing an estimated 480,000 deaths every year. With about 34.1 million Americans smoking cigarettes, there is a growing need for smoking cessation alternatives, an opportunity that Mydecine is looking to tap into. “Tobacco use is the greatest single, preventable cause of death in the world, yet there are few safe and effective treatments for nicotine addiction,” noted Mr. Bartch. “With safety and efficacy concerns about current therapies, including the recall of the blockbuster treatment Chantix, there is a strong need for innovative and improved treatment options,” acknowledged Dr. Rakesh Jetly, the Chief Medical Officer (“CMO”) at Mydecine. The pre-IND briefing package submission edges Mydecine closer to launching its MYCO-001 to the market. It is a tremendous milestone for the company and shows great promise for smoking cessation treatments. In addition to smoking cessation, Mydecine is also exploring the use of psilocybin in treating Post-Traumatic Stress Disorder (“PTSD”). In what marks another significant move for the company, it just entered into a partnership with Combat Stress to use psilocybin in a psychedelic-assisted psychotherapy PTSD treatment program for veterans (https://ibn.fm/Gp3u9). The company further confirmed that Combat Stress, one of the leading charities in the United Kingdom working with veterans, will be one of the several sites for its upcoming clinical trials, set to launch later in the year. The study will be led by Professor Dominic Murphy, the Head of Research at Combat Stress and the UK Psychological Trauma Society’s president. “I am truly excited to be leading this study at Combat Stress,” noted Professor Murphy. “This collaboration offers great potential for research focused on new, innovative therapeutics that offer significant opportunities to bring hope to those veterans still living with the trauma of their military experiences,” he added. Data collected from this study will be integral to Mydecine advancing its drug development pipeline, coupled with its ability to bring a much-needed novel treatment to market. The company is also confident that there are more opportunities to expand its clinical trials and deliver on its mission to come up with safe and effective alternative medicine that people can trust with this partnership. “There is a big unmet need when it comes to treating PTSD and other mental health conditions, especially within the veteran population, and this partnership demonstrates the strong progress we continue to make in bringing psychedelic-assisted psychotherapies to the forefront of the market and bring hope for all those struggling with these conditions,” reckoned Mr. Bartch. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

• Tingo has made it its corporate mission to transform the way rural business in Africa is conducted, thereby helping millions of people across Africa improve their economic prospects
• The company has based their business model around several key tenets, namely – the provision of technology through its unique ‘device-as-a-service’ model, access to financial services through TingoPay and access to market through Nwassa digital Agri-Marketplace
• Alongside its corporate aspirations, Tingo has also adopted a number of the United Nations Sustainable Development Goals (“SDG’s”), through which it seeks to invest in the future of its millions of stakeholders

For the past 50 years, Daisy Namusoke has grown crops on her small plot of land in the Buikwe District of Central Uganda, mostly to feed her husband, five children, and two grandchildren (https://ibn.fm/RdC8O). Like most smallholder farmers in Africa, she cultivates a mix of crops, relies on saved seeds and those purchased from local sources, and uses little by way of external inputs, such as synthetic fertilizers. When selling her crops, she is forced to sell to middlemen – a practice which subjects’ farmers to thin margins and habitually short-changes them on the fruit of their labor. Tingo (OTC: TMNA), a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa, has made it its mission to change the way rural business in Africa is conducted, in the process helping millions of people across the continent improve their quality of life, income and prospects. The agricultural sector is the largest economic sub-set within Nigeria’s economy, representing 24 percent of the country’s Gross Domestic Product (“GDP”) as of 2020 and playing a pivotal role in the growth of the country. The crucial role of the sector has driven Tingo towards addressing some of the principal challenges that farmers and other stakeholders within the Nigerian agricultural value chain are current facing. Tingo’s business model is underpinned by four key pillars, namely – Device-as-a-Service, whereby farmers are provided access to smartphones and mobile internet; Tingo Mobile Network; which seeks to provide mobile connectivity and reception in remote and rural locations; TingoPay, a unique Africa-centric payments service; and Nwassa, their digital agricultural marketplace. Through the combination of the four pillars, Tingo has sought to bundle a complete, digitally inclusive ecosystem which promotes financial inclusion, delivers disruptive micro-finance solutions, produces social upliftment in rural communities and unveils domestic and international opportunities to Africa’s rural farmers. Tingo’s Nwassa platform has rapidly become a key tool for the close to 10 million agri customers and stakeholders that the company supports. Third quarter results revealed that the platform has generated $120.7 million as income as of the first nine months of 2021. By year-end, the Nwassa platform is forecast to have processed up to $4 billion in transactions, the process generating upwards of $160 million earnings, which in turn will account for approximately 38 percent of Tingo Inc’s revenues, up from only 17 percent in 2020. Tingo’s business model has, rather uniquely, sought to deliver attractive returns to shareholders whilst simultaneously, investing in the long-term future of the company and its millions of stakeholders. To do so and in addition to its commercial focus, the company has adopted five core sustainable development goals as its corporate mission, namely – ensuring food security, driving poverty alleviation, promoting digital financial inclusion, encouraging job creation, and supporting female entrepreneurship and empowerment. Over the past 20 years, Tingo has sought to commit towards developing solutions which support the long-term aspirations of rural farming communities across the African continent. Driven by an unrelenting mission to uplift rural communities and support growth in developing economics, Tingo Inc has shown that it is indeed possible to achieve the most sought-after maxim in impact investing today – making returns whilst doing good. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to TMNA are available in the company’s newsroom at https://ibn.fm/TMNA

Businesses, HR managers, and corporate leaders are invited to attend the Future Workforce Conference on February 16-18, 2022, as a virtual online event. The conference sessions are specially curated for industry decision-makers who have responsibilities in Human Resources, Employee Experience & Engagement, Learning and Development, Talent Acquisition, Workforce Strategy & Development, Change Management, Performance Management, Strategic Planning, People Data & Analytics Strategy, and so on. At the Future Workforce Conference, vendors can directly connect with the target businesses investing in digital, remote, and hybrid workforce in their organizations. Top reasons to attend:

• Learn to build a robust workforce strategy
• Incorporate new skills and collaborations through human-machine collaboration
• Driving digital innovations and transformation within the organization
• Understand and utilize people analytics for talent acquisition and retention
• Learn and get inspired from peers and understand what is driving other workforces
• Witness the enigmatic gathering of experts and corporate decision-makers

The event will discuss eminent speakers discussing the best practices for virtual onboarding remote workers in an organization. The conference will commence with opening keynotes about the human approach to workplace culture. The agenda on day 2 of the event includes discussions on talent acquisition, operations and analytics in the future of work. HR leaders will speak about the HR digital strategies and the evolving role of an HR professional. Further, the strategies for hiring employees in the post-pandemic era as well as digital transformation and the future of work will be some important topics at the conference. Industry decision-makers will share insights on digital listening strategies which is the key for an elevated employee experience. The Future Workforce Conference will showcase a panel of speakers discussing the future of HR technology, workforce development and employee experience. The speaking faculty includes HR heads, business partners, and workforce strategists of global organizations who possess years of experience in their work area. Attendees can leverage this phenomenal platform to connect with industry leaders. They can discuss their queries as well as learn tips and technologies of the evolving workforce strategies in the emerging digital landscape. To learn more, please visit https://ibn.fm/Gi21v.

• Legal cannabis market forecast to grow 20–30% per year to $50 billion by 2026
• “Cannabis industry in America is flourishing,” reports CNN Business
• ACP positioning itself in four sectors of the cannabis space: real estate, cultivation, medical research and nonprofit groups

The future of cannabis is looking promising, according to several recent reports, and companies such as American Cannabis Partners (“ACP”) are positioning themselves to benefit from the projected growth. “Various states across the country are resurfacing from the cloud of COVID-19, and as some like New York seek new high-growth industries to have a hand in, cannabis has been a consistent answer,” reported Forbes (https://ibn.fm/oqn9k). “Sales from cannabis were $20 billion in 2020, and are expected to exceed $26 billion in 2021. Research conducted by Cowen and Company reveals that the legal cannabis market is bound to grow 20–30% per year to the price of 50 billion by 2026. “There has always been a strong case for investment on the health side of the legalization debate, as patients suffering from chronic illnesses, such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders, are administered by medical cannabis,” the article continued. “But recreational use of the product has gained increasing momentum. Moreover, robust programs are touted to reinvest millions of tax revenues from cannabis into minority communities that the war on drugs has historically victimized.” CNN Business is touting the potential of cannabis. “Despite a global pandemic, discombobulated supply chains, ballooning inflation and an ongoing fight to legalize marijuana on a federal level, the cannabis industry in America is flourishing,” the news site stated (https://ibn.fm/YKYP6). “Sales hit $20 billion in 2020, are on pace to top $26 billion this year, and are projected to leapfrog to $45.9 billion in 2025, according to data from Marijuana Business Daily that were shared at the MJBizCon, the industry’s annual trade show. The nearly $46 billion in sales would make the cannabis industry larger than the craft beer industry.” These projections bode well for American Cannabis Partners, which is a fully licensed, large-scale, 100% organic cannabis cultivation company. The company is positioning itself in four sectors of the cannabis space: real estate, cultivation, medical research and nonprofit groups. American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses in both the medical and recreational markets. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. The company is currently operating in two states — California and Michigan — with a total of 12 cannabis licenses, including 20,000 square feet of cultivation licenses in California and 540,000 square feet of cultivation licenses along with a retail license in Michigan. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

• E-commerce and retail brick-and-mortar plant-based lifestyle champion PlantX Life is a growing company focused on providing plant-based products and information to a booming community of health-conscious consumers
• PlantX Life markets over 5,000 products that will serve local plant-based communities while also serving as fulfillment centers for the company’s growing e-commerce operations
• The company’s most recent openings include stores in the Chicago area that will serve the U.S. Midwest, acquired from plant-based market Peter Rubi
• PlantX further serves the plant-based community through informative podcasts, VIP YouTube interviews and a company blog

The growing appeal of a healthier, plant-based diet is evident in the number of people making the transition to veganism worldwide. While the statistics are hard to pin down precisely, the Plant Proteins papers found the number of vegans in the United States has increased by 600 percent since 2014 (https://ibn.fm/8Py2P) and the Guardian reported that the participants in the annual January vegan event “Veganuary” was expected to rise from a record 580,000 last year to more than 2 million this year (https://ibn.fm/lQwLC). Veganuary’s 2021 report noted that people from 209 countries participated in the month-long go-vegan challenge (https://ibn.fm/Od6hs). But transition to a vegan diet also comes with some negative side-effects that may discourage people from sticking with the changes they’ve made to their lifestyle in pursuit of better health (https://ibn.fm/veQXl). Progressive plant-based lifestyle platform builder PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has developed a growing slate of online resources to help educate people about plant-based living while simultaneously building a North American product distribution network — all part of its mission to be a one-stop shopping source for the plant-based community. Recent posts on the company’s blog (https://ibn.fm/Zv5G7) tout everything from the benefits of a delicious vegan hot chocolate during the winter months to air-purifying plants that not only add to a home’s decor but its overall health as well. The company’s YouTube channel (https://ibn.fm/LEcpS) features its new “Medically Speaking” science-based programming as well as a variety of streams that provide information on recipes, fitness, and associated social matters. The PlantX video podcast series (https://ibn.fm/YoWP1) features interviews with business entrepreneurs, athletes and other notables who’ve dedicated themselves to making the plant-based lifestyle journey. “I always tell people it’s about progress, not perfection,” Olympic skier Julia Murray, who retired from competition to focus on building a breakfast cereal company and becoming a nutritionist, told PlantX founder Sean Dollinger during one of the Vodcasts. “I took about a year to transition from getting interested in eating more plants to fully calling myself vegan and using that label. … We always ate a lot of plants but I started just ditching the beef first and then the chicken and the pork and all of the meat and once I started ditching dairy especially I started noticing less inflammation overall and my skin cleared up as well, so it’s kind of a process.” PlantX has been adding e-commerce operations and retail outlets to help supply the growing demand for plant-based products. The company expects to have additional locations open by the end of this year, which will serve their local communities while also performing a vital function as fulfillment centers for the growing e-commerce infrastructure. Among the most recent openings celebrated by PlantX are two Chicago-area stores acquired from plant-based market and e-commerce platform Peter Rubi. The Uptown Chicago store will rebrand under PlantX’s Xmarket umbrella, while the Plainfield store on the southwest edge of the metropolitan area will retain the Peter Rubi name, adding “by PlantX.” Starting Feb. 15, the stores will only carry 100 percent plant-based items and will begin offering weekly sampling sessions to give shoppers opportunities to try new brands (https://ibn.fm/QP7Yt). The stores will help fulfill e-commerce orders and enhance the company’s e-commerce success in the U.S. Midwest. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Laredo received a reserve report valuing a small portion of its subsidiary’s Western Williston Basin properties interests at $41 million of cumulative cash flow (discounted at 10%)
• CEO Mark See highlighted the report as confirmation of potential for the first 10 well package at the property in northeast Montana
• Oil price forecasts have risen sharply early in 2022 with growing geopolitical tension, declining global production and rebounding demand

Laredo Oil (OTC: LRDC), an oil and gas exploration and production (E&P) company, is focused on acquiring, developing and operating conventional oil and gas properties. During a recent down cycle, the company leased 23,739 mineral acres in the Western Williston Basin of Montana at favorable prices, and it continues to make progress toward developing this asset. In November, Laredo announced receiving a reserve report from an independent petroleum engineering firm estimating that interests attributable to certain properties in the Western Williston Basin of Montana acquired by Laredo subsidiary Lustre Oil Company LLC have a present total worth of “$41 million of cumulative cash flow discounted at 10%.” “This reserve report confirms the potential of the first 10 wells we have identified for completion in a small portion of the 23,739 acres where Lustre has acquired mineral rights in northeast Montana,” Mark See, Chairman and CEO of Laredo, said in the news release. “Based on this reserve report, I feel the field has much more potential for expansion.” Montana’s Western Williston Basin has an extensive production history dating back to the 1950s. Notably, the area features shallow well depths ranging from 4,000 to 7,000 feet, enabling the use of conventional vertical well applications that offer less inherent risk and costs than areas requiring unconventional recovery techniques and horizontal wells. The outlook for oil prices has soared early in 2022, as geopolitical tension continues to increase, and global demand recovers as fears surrounding the omicron coronavirus variant dissipate (https://ibn.fm/ggo2D). A Monday report from Reuters pegged Brent crude forecasts at $79.16 per barrel this year, up from an estimate of $73.57 in December. Meanwhile, demand is seen growing by “3-5 million barrels per day in 2022, with analysts seeing a muted impact from the current COVID-19 surge.” For Laredo, these market projections are promising. The company remains committed to value, growth upside and free cash flow, and its management team has noted an interest in aggressively pursuing the acquisition of quality assets that major, mid-major and large independent oil and gas companies continue to divest themselves of. For more information, visit the company’s website at www.Laredo-Oil.com. NOTE TO INVESTORS: The latest news and updates relating to LRDC are available in the company’s newsroom at https://ibn.fm/LRDC

• Joël Reyes’ appointment marks the third appointment in the first month of the 2022 calendar year
• Mr. Reyes will be responsible for implementing operational excellence across the entire organization, starting with its Columbian activities
• His appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower

Flora Growth (NASDAQ: FLGC) embarked on an aggressive hiring campaign to kick off the 2022 calendar year, starting with the appointment of Derek Pedro as an advisor to its Cosechemos cultivation facility (https://ibn.fm/BNmVY). This was then followed by the nomination of Tim Leslie as Chairman of its newly formed Advisory Board, all in a move to develop its corporate structure further to include a robust roster of human capital (https://ibn.fm/etalw). The latest addition to the Flora Growth team is Joël Reyes, a seasoned operations and personnel development expert. Mr. Reyes will serve as the company’s Senior Vice President (“SVP”) of Global Operations. He will be responsible for implementing operational excellence across the entire organization, starting with its robust Columbian activities (https://ibn.fm/ZUqXO). Mr. Reyes will lend his years of experience in operations management and optimization, business development, strategic consultative sales, and C-suit consultation and development. Flora Growth’s management is confident that his addition to the team will play a vital role in achieving the company’s aggressive global expansion plan. “2022 is the year for Flora to rapidly grow sales and revenue, and being surgical in our operational execution at every touchpoint will be critical to achieving our goals,” noted Luis Merchan, the President and Chief Executive Officer (“CEO”) of Flora Growth Corp. “As an award-winning expert in operations management, the appointment of Joël Reyes comes at the perfect time as Flora Growth’s aggressive global brand expansion and M&A strategy continue to be implemented,” he added. Mr. Reyes has founded four startups over his professional career. This achievement has awarded him an intimate understanding of the level of consistency, determination, and commitment required to deal with challenges and achieve goals at scale. It has also led to him being named one of the “Faces of Innovation” by the Consumer Technology Association (“CTA”). When accepting his appointment, Mr. Reyes noted: “Flora Growth is well-positioned for rapid revenue growth after strategically building a house of brands and global pipeline for the sale of cannabis derivatives in 2021. With this growth, combined with aggressive revenue targets, comes the need for operational acuity within every go-to-market pillar, across every market we enter – and that is the work I most look forward to taking on, alongside this all-star team.” Mr. Reyes’ appointment comes just in time, following the implementation of the new Colombian law allowing for the export of up to 7,900 kilograms of high-THC cannabis dried flower. Flora Growth is in the process of ramping up production at its Cosechemos facility to meet this quota, and Mr. Reyes will play an integral role in achieving this objective. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

• GreenBox POS will begin offering bulk Automated Clearing House (“ACH”) processing capabilities to merchants utilizing its innovative blockchain and smart contract technologies
• ACH payments offer an affordable alternative when compared to traditional debit and credit cards
• GreenBox POS CEO Fredi Nisan stated that bulk ACH processing offers a new, profitable multi-billion-dollar revenue stream for the company
• The launch will secure the company’s ability to continue providing meaningful value to its shareholders and customers while also growing its processing volumes

When GreenBox POS (NASDAQ: GBOX), a fast-rising provider of customized payment solutions leveraging advanced, secure blockchain and smart contract token technologies, launched the third generation of its proprietary blockchain-based platform (“Gen3”) early last year, its objective was clear – to unlock the door to rapid scalability. Gen-3 positioned the company vertically within the payment processing space, enabling it to capture a significant share of the transaction volume. For instance, the company last November reported a year-to-date transaction volume of $1.4 billion as of September 30, 2021 (https://ibn.fm/O1wJv). Additionally, Gen3 allowed GreenBox to create a tokenized ecosystem, fast-track the onboarding of new merchants, offer white label banking solutions, and enter new verticals (https://ibn.fm/wS74l). Consistent with the latter outcome, the company celebrated the launch of a massive new payment vertical, announcing January 18 that it would offer Automated Clearing House (“ACH”) processing capabilities to merchants. GreenBox will leverage its blockchain technology as well as smart contract technology to transfer funds electronically for ACH debit and ACH credit transactions. Already, GreenBox clients have committed more than $50 million in monthly ACH processing since the program began; the number is growing by the day. “Generally, the average ACH ticket is approximately $150.00, with margins ranging from 20-30 cents per transaction. What’s more is that these new ACH processing abilities also allow the company to capture the business of and support clients in higher-risk categories, earning an additional 20-30 basis points per transaction,” GreenBox’s POS Chief Executive Officer, Fredi Nisan, said in the news release. ACH is a network payment system that facilitates the transfer of billions of dollars through the United States financial system daily. It handles credit transfers, including but not limited to social security benefits, direct deposit of paychecks, dividend payouts, and tax refunds, as well as debit transfers such as subscription and mortgage payments and utility bills. It boasts low execution costs, making ACH payments an attractive and advantageous payment alternative for merchants – it offers substantial cost savings to conventional credit and debits cards. In 2020, ACH processed 26.8 billion payments whose total value crossed the $61.9 trillion mark, according to Nacha, a nongovernment agency that governs the network (https://ibn.fm/gZUd8). “ACH bulk processing offers a profitable, new, multi-million-dollar revenue stream for GreenBox. Our clients have long been demanding it, and now we can offer it with our superb technology,” commented GreenBox POS CEO Fredi Nisan. “This is yet another example of GreenBox delivering against our strategic plan to continue providing meaningful value to our shareholders and customers alike.” The launch of the new ACH bulk processing initiative aligns perfectly with GreenBox’s goal of increasing its overall processing volume. Speaking during a December corporate update call, company COO Vanessa Luna noted, “Processing volume is one of the key pillars of our organization, and it is, in fact, the one that [we] measure our success on” (https://ibn.fm/QTgjZ). Guided by the focus on growing processing volume, GreenBox has continued to execute various mergers and acquisitions and has, in fact, scheduled additional strategic acquisitions for 2022. “The purchases,” Luna said, “create a stable infrastructure to support payment processing and contribute to the bottom-line goal.” At the same time, GreenBox aims to continually expand its licensing and broaden its network and processing capabilities. For more information, visit the company’s website at www.GreenBoxPOS.com. NOTE TO INVESTORS: The latest news and updates relating to GBOX are available in the company’s newsroom at https://ibn.fm/GBOX

• Apple enthusiasts buy the company’s products chiefly because of the ecosystem of software and services that allow them to enjoy numerous tools and Apple-only applications
• This unique selling point could equally influence people who currently own Apple products to buy Apple ecosystem compatible smart home devices built on the HomeKit framework
• SPYR, through its wholly-owned subsidiary, Applied Magix, offers white-label HomeKit products and accessories, but ultimately intends to develop, manufacture, and sell its own line of branded products based on the HomeKit framework

During the 2020 Worldwide Developers Conference (“WWDC”), Apple Inc. (NASDAQ: AAPL) announced an update to HomeKit – the company’s framework, which pairs compatible smart home devices with the iPhone via Apple’s Home app, enabling users to centrally control the devices, automate certain operations, and use voice commands – that observers believed would boost its smart home efforts (https://ibn.fm/ijb0G). The update would allow HomeKit to provide recommendations that optimize the automation potential of smart home devices, solving a glaring problem afflicting users at the time – the complexity of automating different smart home devices. In addition, the update would enable users of smart home accessories to link their devices’ video cameras to Apple products in what would promote on-device security by allowing the cameras to support facial recognition. The 2020 announcement was the latest, at the time, in a series of improvements Apple had continuously promised and delivered since the release of the first version of HomeKit in September 2014, as it sought to lock its consumers more tightly within the Apple ecosystem – a collective of services and software that allow users of Apple products to enjoy a plethora of useful and convenient capabilities. Though Apple has been a laggard in the smart-home market, falling behind Amazon.com, Inc (NASDAQ: AMZN) and Google Inc., a subsidiary of Alphabet Inc. (NASDAQ: GOOGL), its ecosystem and the convenience it offers could ultimately fuel the company’s growth within this space. A 2017 CNBC All-America Economic Survey established that 64% of Americans owned an Apple product, up from 50% in 2012. The average U.S. household reported owning 2.6 Apple products, while the wealthiest Americans owned 4.7 products (https://ibn.fm/N2kJk). These figures have likely increased since 2017 based on the historical trend. Meanwhile and according to a 2021 Statista report, 43% of American households reported owning a smart home device, up from 33% in 2019. The trend is also likely to continue as more devices that can connect to the internet enter the market (https://ibn.fm/udLjj). The variance between the number of Americans who have owned an Apple product and those who have owned a smart home device represents a significant growth potential for Apple’s smart home device segment, especially in light of the significance of the company’s ecosystem. And while the company’s HomeKit framework is not compatible with as many smart home devices as Google Assistant and Amazon Alexa, third-party companies are filling the gap. One such company is Applied Magix Inc., a wholly-owned subsidiary of SPYR (OTCQB: SPYR). Acquired in October 2020 (https://ibn.fm/in0HE), just a few months after Apple’s WWDC, Applied Magix is a registered Apple developer and reseller of Apple ecosystem compatible products targeting the burgeoning multi-billion-dollar smart home market. Applied Magix sources white-label HomeKit products and accessories from manufacturers and selects the best-in-class products that it then sells and offers support services such as software updates. The subsidiary’s goal, however, is to eventually develop, manufacture, and sell its own line of branded products that are based on Apple’s framework. In the meantime, Applied Magix offers the MagixDrive Wireless CarPlay Adapter; the HomeKit Secure Video Camera with iCloud Storage; the Multipurpose Sensor with Alarm; the Environment and Motion Sensor; the Window and Door Contact Sensor; and the newly introduced MagixBlock USB DataBlocker (https://ibn.fm/TRqwz). For product information, please see the Applied Magix website at https://AppliedMagix.com, or specific product sites:

• MagixDrive Wireless CarPlay Adapter –  https://appliedmagix.com/MagixDriveBundle
• HomeKit Secure Video Camera with iCloud Storage – https://appliedmagix.com/HomeKitCamera
• Multipurpose Sensor with Alarm – https://appliedmagix.com/HomeKitAlarmSensor
• Environment and Motion Sensor – https://appliedmagix.com/HomeKitMotionSensor
• Window and Door Contact Sensor – https://appliedmagix.com/HomeKitContactSensor
• MagixBlock USB DataBlocker – https://appliedmagix.com/MagixBlock
• MagixCharge Dual USB-C Car Charger – https://appliedmagix.com/MagixCharge

For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR